Reuters logo
BRIEF-SINEW Pharma says fatty hepatitis new drug SNP-610 passes Fast track plan
December 6, 2017 / 3:07 AM / 11 days ago

BRIEF-SINEW Pharma says fatty hepatitis new drug SNP-610 passes Fast track plan

Dec 6 (Reuters) - SINEW Pharma Inc :

* Says its fatty hepatitis new drug SNP-610 passed Fast track plan and got subsidy of T$2.2 million

Source text in Chinese: goo.gl/Ws7iUY

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below